Näslund TI - Search Results

1

Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.

Gehrmann U, Hiltbrunner S, Georgoudaki AM, Karlsson MC, Näslund TI, Gabrielsson S. Gehrmann U, et al. Among authors: naslund ti. Cancer Res. 2013 Jul 1;73(13):3865-76. doi: 10.1158/0008-5472.CAN-12-3918. Epub 2013 May 8. Cancer Res. 2013. PMID: 23658368

2

Dendritic cell-derived exosomes need to activate both T and B cells to induce antitumor immunity.

Näslund TI, Gehrmann U, Qazi KR, Karlsson MC, Gabrielsson S. Näslund TI, et al. J Immunol. 2013 Mar 15;190(6):2712-9. doi: 10.4049/jimmunol.1203082. Epub 2013 Feb 15. J Immunol. 2013. PMID: 23418627

3

Potentiating antitumor immunity with αGC-loaded exosomes.

Gehrmann U, Hiltbrunner S, Näslund TI, Gabrielsson S. Gehrmann U, et al. Among authors: naslund ti. Oncoimmunology. 2013 Oct 1;2(10):e26261. doi: 10.4161/onci.26261. Epub 2013 Oct 10. Oncoimmunology. 2013. PMID: 24353911 Free PMC article.

4

Harnessing the exosome-induced immune response for cancer immunotherapy.

Gehrmann U, Näslund TI, Hiltbrunner S, Larssen P, Gabrielsson S. Gehrmann U, et al. Among authors: naslund ti. Semin Cancer Biol. 2014 Oct;28:58-67. doi: 10.1016/j.semcancer.2014.05.003. Epub 2014 May 22. Semin Cancer Biol. 2014. PMID: 24859748 Review.

5

Exosomes from antigen-pulsed dendritic cells induce stronger antigen-specific immune responses than microvesicles in vivo.

Wahlund CJE, Güclüler G, Hiltbrunner S, Veerman RE, Näslund TI, Gabrielsson S. Wahlund CJE, et al. Among authors: naslund ti. Sci Rep. 2017 Dec 6;7(1):17095. doi: 10.1038/s41598-017-16609-6. Sci Rep. 2017. PMID: 29213052 Free PMC article.

6

Cancer immunotherapy with exosomes requires B-cell activation.

Näslund TI, Gehrmann U, Gabrielsson S. Näslund TI, et al. Oncoimmunology. 2013 Jun 1;2(6):e24533. doi: 10.4161/onci.24533. Epub 2013 Apr 16. Oncoimmunology. 2013. PMID: 23894715 Free PMC article.

7

Soluble and Exosome-Bound α-Galactosylceramide Mediate Preferential Proliferation of Educated NK Cells with Increased Anti-Tumor Capacity.

Wagner AK, Gehrmann U, Hiltbrunner S, Carannante V, Luu TT, Näslund TI, Brauner H, Kadri N, Kärre K, Gabrielsson S. Wagner AK, et al. Among authors: naslund ti. Cancers (Basel). 2021 Jan 15;13(2):298. doi: 10.3390/cancers13020298. Cancers (Basel). 2021. PMID: 33467442 Free PMC article.

8

Exosomes from breast milk inhibit HIV-1 infection of dendritic cells and subsequent viral transfer to CD4+ T cells.

Näslund TI, Paquin-Proulx D, Paredes PT, Vallhov H, Sandberg JK, Gabrielsson S. Näslund TI, et al. AIDS. 2014 Jan 14;28(2):171-80. doi: 10.1097/QAD.0000000000000159. AIDS. 2014. PMID: 24413309

9

Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor.

Näslund TI, Uyttenhove C, Nordström EK, Colau D, Warnier G, Jondal M, Van den Eynde BJ, Liljeström P. Näslund TI, et al. J Immunol. 2007 Jun 1;178(11):6761-9. doi: 10.4049/jimmunol.178.11.6761. J Immunol. 2007. PMID: 17513723

10

Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines.

Näslund TI, Kostic L, Nordström EK, Chen M, Liljeström P. Näslund TI, et al. Virol J. 2011 Jan 24;8:36. doi: 10.1186/1743-422X-8-36. Virol J. 2011. PMID: 21261958 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters